Center-Generated Peer-Reviewed Publications

  1. Oakley GP Jr. (2009). The Scientific Basis for Eliminating Folic Acid-Preventable Spina Bifida: A Modern Miracle from Epidemiology. Ann Epidemiol;19:226-230.
  2. Kancherla V, Weakland A, Walani S, Bauwens L, Warf B, Oakley GP Jr. (2017). Scorecard for spina bifida research, prevention, and policy – A development process. Prev Med;99:13-20.
  3. Kancherla V, Elliott JL Jr, Patel BB, Holland NW, Johnson TM 2nd, Khakharia A, Phillips LS, Oakley GP Jr., Vaughan CP. (2017). Long-term metformin therapy and monitoring for vitamin B-12 deficiency among older Veterans. J Am Geriatric Soc;65(5):1061-1066.
  4. Mukhtar A, Kramer MR, Oakley GP Jr., Kancherla V. (2017). Race and Ethnicity and preconceptional folic acid supplement use among women of reproductive age in Georgia, PRAMS 2009 to 2011. Birth Defects Res Part A Clin Mol Teratol;109(1):38-48.
  5. Kancherla V, Garn J, Zakai NA, Williamson RS, Cashion WT, Oluwaseun O, Judd S, McClellan W, Oakley GP Jr. (2016). Multivitamin use and serum vitamin B-12 levels in older-adult metformin users in REGARDS, 2003-2007. PLoS One;11(8):p.e0160802.
  6. Arth A, Kancherla V, Pachón H, Zimmerman S, Johnson Q, Oakley GP Jr. (2016). Status of global prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol;106(7):520-9.
  7. Oakley GP Jr., Kancherla V. (2016). Will the Eastern Mediterranean Region be the first to prevent all of folic acid preventable-spina bifida and anencephaly? Saudi Med J;37(1):10-11.
  8. Obeid R, Pietrzik K, Oakley GP Jr., Kancherla V, Holzgreve W, Wieser S. (2015). Preventable neural tube defects in Europe. Birth Defects Res A Clin Mol Teratol;103(9):763-71.
  9. Kancherla V, Druschel CM, Oakley GP Jr. (2014). A population-based study to investigate mortality in spina bifida – New York State Congenital Malformations Program. Birth Defects Res A Clin Mol Teratol;100(8):563-75.
  10. Kancherla V, Oakley GP Jr., Brent RL. (2013). Urgent global opportunities to prevent birth defects. Semin Fetal Neonatal Med;19(3):153-60.
  11. Youngblood M, Williamson R, Bell KN, Johnson Q, Kancherla V, Oakley GP Jr. (2013). A 2012 Update on Global Prevention of Folic Acid-Preventable Spina Bifida and Anencephaly. Birth Defects Res A Clin Mol Teratol;97(10):658-63.
  12. Pachon H, Kancherla V, Handforth B, Tyler V, Bauwens L (2013). Folic-acid fortification of wheat flour:  A cost-effective public-health intervention to prevent birth defects in Europe. Nutrition Bulletin;38:201-09.

Publications Under Review

  1. Kancherla V, Hasan MOS, Hamid R, Oakley GP Jr., Rahman M, Quamruzzaman Q, Mazumdar M. Prenatal folic acid use associated with decreased risk of myelomeningocele: Further support for folic acid fortification in Bangladesh. Submitted to PLoS One (Dec 2016)